Objective: The possible effect of obesity in the outcome of treated children with abdominal pain-related functional gastrointestinal disorders (FGIDs) has not yet been studied. We hypothesized that obesity is associated with a poor long-term prognosis in children with FGIDs. Study design: Prospective cohort study in an outpatient clinic-based sample of patients diagnosed with abdominal pain-related FGIDs. Principal outcome measured was persistence of pain at long-term follow-up (12-15 months). Frequency of pain, intensity of pain, school absenteeism and disruption of daily activities were compared between obese and non-obese subjects. Results: The group mean age was 13.27 ± 3.84 years, distribution of diagnosis was 32% (functional abdominal pain), 42.5% (irritable bowel syndrome) and 25.5% (functional dyspepsia). Overall, 20.2% of patients were obese. A total of 116 patients (61.7%) reported abdominal pain and 72 (38.3%) were asymptomatic at long-term follow-up. Obese patients were more likely to have abdominal pain (Po0.0001), higher intensity of pain (P ¼ 0.0002), higher frequency of pain (P ¼ 0.0032), school absenteeism (Po0.0001) and disruption of daily activities (Po0.0001) at follow-up than non-obese patients. Conclusion: Obesity is associated with poor outcome and disability at long-term follow-up in children with abdominal pain-related FGIDs. Our novel findings could have important implications in the prognosis and management of FGIDs.
Introduction
Functional gastrointestinal diseases (FGIDs) are one of the most common gastrointestinal (GI) disorders in children accounting for more than 50% of the consultations in pediatric gastroenterology and 2 to 4% of all general pediatric office visits. 1, 2 FGIDs exert a significant impact on children's health, with individuals affected having poorer quality of life, increased psychological comorbidities, school absenteeism and parental-work absences. 3 Childhood obesity is a growing public health problem. The prevalence of childhood obesity has significantly increased over past decades. 4, 5 The effects of obesity are multiple, and include medical, psychological and economic consequences to the obese individual, as well as healthcare and productivity costs to society. 6 There is increasing evidence of the existence of an association between obesity, FGIDs and related GI symptoms. Epidemiological studies in adult populations have shown that increased body mass index (BMI) is associated with GI symptoms, including nausea, vomiting, bloating, diarrhea and abdominal pain. 7, 8 Studies in children have also found an association between these two prevalent conditions. Obese children are more likely to report abdominal pain than their non-obese counterparts. 9 Teitelbaum et al. compared the prevalence of FGIDs in obese patients referred to a pediatric gastroenterologist with healthy ageand sex-matched controls. A greater percentage of FGIDs, including constipation, gastroesophageal reflux disease, irritable bowel syndrome (IBS), fecal soiling and functional abdominal pain (FAP) were found among obese patients. 10 An important aspect that has not yet been explored is whether obesity influences the outcome of FGIDs. Understanding the interaction between these two highly prevalent childhood conditions could have important implications in the management of FGIDs. We conducted a prospective cohort study among children with FGIDs to evaluate the effect of obesity on the long-term outcome. We hypothesized that obesity is associated with a poor prognosis in children with FGIDs. 
Patients and methods

Subjects
Obesity measures
Obesity was defined as a BMI at or above the 95th percentile for children of the same age and gender according to CDC definitions. 4, 5 Data on children's weight changes during the follow-up period was based on chart review and parental information given at the time of the telephone interview.
Treatment
Treatment was tailored to each child and consisted of reassurance, education, medication and/or psychological treatment as deemed appropriate by the treating medical care provider and the family. Data on adherence to medical therapy was based on chart review and parental information given at the time of the telephone interview.
Assessment of symptoms
Data regarding intensity of pain at baseline was obtained by chart review. Patients were contacted by telephone between 12 to 15 months after diagnosis and initiation of treatment of FGIDs, and were requested to complete a validated measure to diagnose functional bowel disorders on the basis of Rome II criteria (Questionnaire on Pediatric Gastrointestinal Symptoms). 11, 12 Persistence of abdominal pain at follow-up was assessed by the following question: Has your child had abdominal pain within the last 2 months? (Yes/No). For the patients that did refer persistence of abdominal pain, abdominal pain frequency and intensity were assessed. Frequency was assessed using the following questions derived from the questionnaire: (1) 'In the last 2 months, how often did your child have a belly ache or pain in the area around or below the belly button?' (never, 1 to 3 times a month, once a week, several times a week, every day), (2) In the past 2 months, how often did your child have pain or discomfort in the upper abdomen above the belly button? (never, 1 to 3 times a month, once a week, several times a week, every day). Intensity was assessed using the following questions derived from the questionnaire: (1) 'In the last 2 months, what was the usual intensity of your child's belly aches or abdominal pain in the area around or below the belly button?' (a little, some, a lot, very lot), (2) 'Is your child's pain or discomfort in the upper abdomen usually' (mild, moderate, severe, very severe)?
School attendance and daily functioning School attendance and disruption of daily activities were assessed with 12 questions (part V) of the Questionnaire on Pediatric Gastrointestinal Symptoms. Each answer category was assigned a score from 0 to 4 (never ¼ 0, once in a while ¼ 1, sometimes ¼ 2, most of the time ¼ 3, always ¼ 4.) Scores for each of the questions for school absenteeism were added and classified into four categories: 0, 1-3, 4-5, and 46 for statistical analysis. The same was carried out for daily functioning with the sum of scores classified into three categories:0, 1-3, and X4.
Statistical analysis
Fisher's exact or w 2 test was used to evaluate association between obesity and GI symptoms. Cochran-Mantel-Haenszel test was performed to test association between obesity and pain intensity, pain frequency, school absenteeism and disruption of daily activities. Cochran-Armitage test was applied to evaluate trends of these variables between obese and non-obese groups. Logistic regression modeling with proportional odds assumption was applied to identify multiple risk factors associated with pain intensity, pain frequency, school absenteeism and disruption of daily activities. Statistical significance was defined as a P-value of o0.05. The analysis was conducted using SAS 9.1 software (SAS Institute Inc., Cary, NC, USA).
Results
A total of 301 patients were identified from which 188 (62%) agreed to participate and were included in the study. The remaining patients either declined to participate or could not be contacted (Figure 1 ). Group mean age was 13.27± 3.84 years. Overall, 94% of patients were white, 3% were black and 3% were Asian. In all, 22% were Hispanic. The frequency distribution of diagnosis was 32, 42.5 and 25.5% for FAP, IBS and FD, respectively (Table 1) . At the time of diagnosis, obesity was present in 20.2% of cases with no significant difference in obesity among genders. Obese and non-obese individuals had similar intensity of symptoms at initial evaluation (P ¼ 0.13).
Patients in the study underwent diagnosis and treatment by seven board-certified pediatric gastroenterologist and two pediatric nurse practitioners. Patients were provided reassurance and education on FGIDs. Treatment interventions included medications such as acid-reduction therapy, antispasmodic agents, smooth muscle relaxants, stool softeners, laxatives, fiber supplements and low dose of psychotropic Childhood obesity and functional disorders S Bonilla et al agents with a small number of patients receiving lubiprostone and probiotics. The majority of patients (74%) received between one and two medications. Overall, 15% of patients received psychological treatment (cognitive behavioral therapy). No significant difference in treatment between obese and non-obese individuals was found. None of patients changed their weight status category for the calculated BMI-for-age percentile during the follow-up period. A total of 116 out of 188 patients (61.7%) reported persistence of symptoms of abdominal pain and 72 patients (38.3%) were asymptomatic at long-term follow-up. Distributions of gender, race, and ethnicity were not significantly different between subjects with abdominal pain and subjects who were asymptomatic. A strong association between persistence of GI symptoms and obesity was found (P ¼ 0.0017). Among symptomatic patients, obesity was present in 31.9% of patients, whereas among asymptomatic patients obesity was present in only 1.4% of patients. Obese subjects experienced more abdominal pain than non-obese subjects for each diagnostic category (P ¼ 0.0034 for FAP, Po0.0001 for IBS, P ¼ 0.0204 for FD) ( Table 2 ). Obese patients were more likely to have abdominal pain (Po0.0001), higher intensity of abdominal pain (P ¼ 0.0002) and higher frequency of abdominal pain (P ¼ 0.0032) at follow-up than non-obese patients (Table 3) . Furthermore, obese patients were more likely to have school absenteeism (Po0.0001) and disruption of daily activities (Po0.0001) than non-obese patients (Table 3) . Analysis of the data of the group of 116 subjects who reported persistent symptoms at follow-up showed that more male subjects were obese than female subjects (P ¼ 0.03). Score is the sum of the scores of six questions addressing daily functioning in Questionnaire on Pediatric Gastrointestinal Symptoms . 
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Distributions of race and ethnicity were not significantly different between obese and non-obese subjects. Analysis based on logistic regression modeling confirmed previous findings and the interaction between obesity and diagnostic category for frequency of pain (P ¼ 0.0079) and intensity of pain (P ¼ 0.0083).
Discussion
Our study found a prevalence of obesity of 20.2% in patients with FGIDs. Our results are consistent with the findings of a recent study conducted in pediatric patients from a tertiary care practice in the state of New Jersey, 10 and with the Behavioral Risk Factor Surveillance System findings in the state of Illinois. 13 Evidence from epidemiological studies suggests an association between childhood obesity and FGIDs. The cross-sectional nature of these studies does not allow evaluation of causality between FGIDs and obesity. Establishing cause and effect between obesity and FGIDs may help delineate pathological mechanisms and potentially direct preventive care. In an effort to better understand the link between these two highly prevalent conditions, we conducted a prospective cohort study aimed at evaluating the effect of obesity on the long-term outcome of children with FGIDs. Our study showed persistence of symptoms in 61.7% of children 12-15 months after standard medical treatment was instituted. These findings corroborate the low response rate to standard medical therapy in children with FGIDs previously reported in the literature.
14,15
The effect of obesity in the long-term outcome of patients with FGIDs has not been previously investigated. Our study found for the first time a strong association between persistence of GI symptoms at long-term follow-up and obesity. This association was also present in the three sub-groups of FGIDs (FAP, IBS and FD). Furthermore, obese patients experienced higher intensity and frequency of abdominal pain, and increased school absenteeism and disruption of daily activities at follow-up than non-obese patients. Environmental, biological or psychological factors may explain this association. Obese patients tend to ingest excess amounts of poorly absorbed sugars (for example, fructose), which in turn can lead to bloating and diarrhea. 16, 17 In addition, binge eating is a common problem among obese children and may contribute to increased GI symptoms. 18 Gastrointestinal neuropeptides could also have a role, particularly the motilin-like peptide ghrelin. 19 Ghrelin potentiates phase III-like gastric contractions, increases gastric acid secretions and gastric-emptying levels. Obese individuals have lower levels of ghrelin and levels have been shown to normalize after diet-induced weight loss. [20] [21] [22] Furthermore, it has been hypothesized that ghrelin exerts an effect on pain modulation in obese individuals through regulation at the brain level. 23 Finally, psychological factors could also be involved. 24 Obese children are more prone to have low self-esteem and higher rates of sadness, loneliness and nervousness, 25 which might lead to an increase in report of GI symptoms. Future studies specially designed to investigate the various factors linking FGIDs and obesity should be conducted. This is the first of a series of studies aimed at achieving a better understanding of the relationship between obesity and FGIDs, two of the most common conditions in children. The findings in our study have important implications in the management and prognosis of FGIDs. Identifying children and families at risk for FGIDs and poor response to medical therapy can potentially aid in the prevention and lead to the design of different treatment strategies for specific groups at risk. This is of outmost importance when considering a group of conditions with unsatisfactory response to treatment. The detrimental effect of obesity in outcome found in our study supports a comprehensive approach for the treatment of children with obesity and FGIDs. A recent meta-analysis found lack of highquality evidence on the effectiveness of dietary interventions in the management of FGIDs in children. 26 However, on the basis of our data, we believe that instituting major educational efforts aimed at promoting better eating habits and physical exercise can potentially improve the outcome of obese children with FGIDs. A recent study showed that only a small percentage of pediatric gastroenterologists (14%) recommended lifestyle changes in patients with FGIDs. 27 Even though patients in our study were seen at a tertiary care center, none of the obese patients had documented counseling on dietary and lifestyle modifications during their visits. As we learn more about the relationship between these two prevalent conditions in childhood, it seems reasonable to intervene as early as possible to potentially prevent the development of functional abdominal pain, and if not possible to improve the response to standard medical treatment precluding abdominal pain from becoming a chronic condition. This approach would optimize medical care and ultimately reduce health care costs and its burden to families and society. Our study is not devoid of limitations. First, data on children's weight change was based on chart review and parental information, and we were not able to obtain objective information about weight changes during the follow-up period. Second, patient's adherence to standard medical therapy during the period of the study was not strictly monitored in all cases. However, data from medical records and parental report at follow-up indicated that most of the patients adhered to their respective therapy. Third, we did not control for specific dietary variables such as ingestion of poorly absorbed sugars. Fourth, we had a relatively high refusal rate. Nevertheless, review of the characteristics of the patients that were not enrolled in the study yielded a similar distribution of variables (BMI, race, sex and age) than the study population. Finally, missing data on the intensity of symptoms at baseline could be a source of potential bias.
Future research should address the limitations of our current study and focus on whether the implementation of lifestyle changes and obesity control results in improvement in the symptoms of FGIDs in pediatric populations. Adult studies have shown clinical improvement of FD and reflux after weight Childhood obesity and functional disorders S Bonilla et al loss, 28, 29 but there is conflicting evidence for other FGIDs. 30 In summary, we found that obesity is associated with poor long-term outcome in children with FGIDs. Obesity is associated with persistence of GI symptoms and disability at long-term follow-up in children with abdominal pain-related FGIDs. Our novel findings could have important implications in the prognosis and management of FGIDs.
